In recent times, the Enzolytics Inc (OTCMKTS:ENZC) stock has been in trading within a range and that is an important thing for investors to note since after such a phase, a stock can often breakout on an upward curve.
While it is true that there has been no news about the company in recent days, it could be a good move to look at a development from last month. Back on June 14, the company announced that it has come up with definitive plans by way of which it seeks to take its ITV-1 anti-HIV product to clinical trials and eventually to distribution all across Europe.
It was a major announcement from the company and one that had come into the attention of many investors. The company also pointed out that once the steps are completed, the anti-HIV product is expected to be a major source of revenues for Enzolytics and it is going to be a major milestone for the company while it gets to help people with their health.
In this regard, it is also important to note that the product had earlier made progress under the auspices of the Bulgarian Drug Agency but the process was not completed.
Market Reaction:
On Friday, ENZC stock fell 1.63% at $0.1873 with more than 11.01 million shares, compared to its average volume of 37.04 million shares. The stock had moved within a range of $ 0.1800 – 0.1930 after opening the trade at $0.1930. Over the past 52-week, the stock has been trading within a range of $0.0003 – 0.9580.
 stock Continues to Trade in a range: Now What?){kind=link}